本页面由Tiger Trade Technology Pte. Ltd.提供服务

BIODEXA PHARMACEUTICALS PLC SPON ADS EACH REP 5 ORD

0.8669
-0.0471-5.15%
盘后0.8299-0.0370-4.27%16:13 EDT
成交量:8.87万
成交额:7.63万
市值:72.72万
市盈率:-0.02
高:0.9200
开:0.9200
低:0.8118
收:0.9140
52周最高:26.50
52周最低:0.8118
股本:83.88万
流通股本:82.75万
量比:1.66
换手率:10.72%
股息:- -
股息率:- -
每股收益(TTM):-53.5009
每股收益(LYR):-144.8126
净资产收益率:-61.77%
总资产收益率:-39.04%
市净率:0.05
市盈率(LYR):-0.01

数据加载中...

2025/12/11

[修订]招股说明书

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2025/12/08

[修订]招股说明书

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2025/11/17

招股说明书

Form F-1 - Registration statement for certain foreign private issuers
2025/09/30

SEC问询函

Form CORRESP - Correspondence
2025/08/20

SEC问询函

Form CORRESP - Correspondence
2025/04/11

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2025/01/24

SEC问询函

Form CORRESP - Correspondence
2025/01/17

招股说明书

Form F-1 - Registration statement for certain foreign private issuers
2024/11/20

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/13

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/07

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/08/16

SEC问询函

Form CORRESP - Correspondence
2024/08/12

招股说明书

Form F-1 - Registration statement for certain foreign private issuers
2024/08/09

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/07/23

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/06/12

SEC问询函

Form CORRESP - Correspondence
2024/06/06

招股说明书

Form F-1 - Registration statement for certain foreign private issuers
2024/04/19

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/03/21

SEC问询函

Form CORRESP - Correspondence